Entero Healthcare Solutions Limited has reported robust financial results for the fiscal year ended March 31, 2026. The company achieved a consolidated revenue of ₹65,912.12 million, demonstrating significant growth compared to the previous year. Alongside these financial achievements, the company announced key leadership re-appointments and a strategic business acquisition of Vishal Surgicals and Vishal Surgicals & Medicals to further strengthen its distribution network in the pharmaceutical and surgical products segment.
Financial Performance Highlights
For the fiscal year ended March 31, 2026, Entero Healthcare reported a consolidated profit for the year of ₹1,458.40 million, marking a substantial increase from ₹1,074.34 million in the previous year. The consolidated revenue from operations reached ₹65,912.12 million, reflecting the company’s sustained growth trajectory. The standalone results also showed strong momentum, with an annual profit of ₹268.75 million.
Strategic Acquisitions and Growth
As part of its inorganic growth strategy, the company is set to acquire Vishal Surgicals and Vishal Surgicals & Medicals through its subsidiary, Sai Pharma Distributors Private Limited. This strategic move, executed via a business transfer agreement, is expected to be completed by December 31, 2026. This acquisition is part of the company’s commitment to expanding its wholesale distribution presence in the pharmaceutical and surgical product sectors across India.
Leadership and Governance
The company announced the re-appointment of its Independent Directors: Mr. Sujesh Vasudevan, Mr. Rajesh Shashikant Dalal, and Ms. Sandhya Gadkari Sharma, all for a second term of five years effective from August 25, 2026. Additionally, the board approved the re-appointment of Ernst & Young LLP as internal auditors for the upcoming 2026-27 financial year, ensuring continued focus on strong corporate governance.
Shareholder Initiatives
Entero Healthcare continues to prioritize employee engagement through its stock option plans. The board approved the allotment of 7,240 equity shares upon the exercise of employee stock options and further noted the grant of 7,300 fresh employee stock options under its current plan. The company also confirmed that its 8th Annual General Meeting is scheduled for August 19, 2026, to be held via video conferencing.
Source: BSE
